News

CRE RESPOND welcomes several international visitors each year to join us at UQCCR. Read about Matteo's experience from his recent visit.

An Early Career Research Fellow and Clinical Research Pharmacist at the University of Queensland Centre for Clinical Research (UQCCR).

The Centre for Research Excellence in Personalising antimicrobial dosing to reduce resistance (CRE RESPOND) recently held a highly successful interdisciplinary and collaborative meeting on transplant and infectious diseases care.

The 2nd Brisbane Transplant Infectious Diseases Meeting, held at the TRI on the Princess Alexandra Hospital campus, brought together local and interstate clinicians, scientists, donor coordinators, pharmacists and other healthcare professionals working in the field of infectious diseases, immunology, and transplant medicine.

Changing the way antibiotics are given to adult patients with sepsis will save thousands of lives a year globally, according to research by The University of Queensland and The George Institute for Global Health.

NHMRC Emerging Leadership Fellow

CRE RESPOND held a highly successful international workshop focused on pharmacokinetic modelling and dose optimization. The three-day event, held at the University of Queensland's exquisite venue, The Atrium on Queen St, brought together experts from around the world to delve into the intricacies of drug dosing and its impact on patient outcomes. 

In collaboration with Flinders University and Alice Springs Hospital, UQ researchers have completed an important study that validated novel antibiotic dosing strategies for Indigenous Australian patients requiring haemodialysis. Read more

Every year CRE RESPOND welcomes several international visitors to join us at UQCCR. Read about Dr Rando's experience spending two months in Brisbane at UQCCR.

CRE RESPOND brings together a team of local, national and international researchers. Read more about A/Prof Landersdorfer's career and research.

UQ researchers will lead a major study on develop personalised fungal infection treatment approaches for cancer patients.

The Centre of Research Excellence RESPOND (CRE RESPOND) presents the 2023 preliminary education program.